Videos

Sergio Calvo, general manager of theranostics at GE HealthCare, discusses the organization's use of theranostics in cancer care and how the technology combines targeted therapy with diagnostic imaging for personalized oncology care.

As medical practices seek to implement agentic AI, Michael Clark, OnPoint Healthcare Partners president, recommends constant oversight to ensure agents' work is repeatable, auditable and traceable by a clinical advisory team.

Alexander Richter, executive director and head of the SciTech Innovation Hub at SciTech Scity, which recently won the World Economic Forum's 2025 Public-Private Collaboration Award, discusses the selection process for piloting and scaling health tech.

Lakewood Health System's Jim Roeder says building regional alliances enables rural hospitals to share expertise, strengthen defenses and keep care available when cyber incidents happen.

The CEO of NeuroOne, Dave Rosa, discusses the company's minimally invasive brain-computer interface thin-film, flexible electrode technology, its successes in patients with seizures and the potential benefits across a range of neurological conditions.

Acting assistant under secretary for health at the U.S. Department of Veterans Affairs at the U.S. Department of Veterans Affairs, Dr. Mark Zhang, discusses the VA's research into 3D-printed biological material for veterans.

Teresa Cope, Manx Care CEO, discusses the Isle of Man's 2026 Innovation Challenge that seeks tools that address the island's health system's needs, including improving access and efficiency for a small, geographically distinct population.

AION Labs CEO, Mati Gill, discusses the company’s extensive backing from pharma and tech giants to build AI startups, and how AION is looking beyond AI to explore quantum technologies for research and development in drug discovery.

Eric Jimenez, Artesia General Hospital CIO, says the hospital first deployed AI to protect its network after a cyber incident. It expanded to ambient listening and is now seeking to use AI for clinical applications.

Michael Abrams of Numerof and Associates says that oversight for AI used in mental health care should mirror that of pharmaceuticals, with clear standards, safety testing and ongoing monitoring.